FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2743134732> ?p ?o ?g. }

• W2743134732 endingPage "279" @default.
• W2743134732 startingPage "265" @default.
• W2743134732 abstract "Fixed-dose combination topical therapy with corticosteroid and vitamin D analog provides effective treatment and possible long-term management of psoriasis. The anti-inflammatory and immunomodulatory effects of corticosteroids and vitamin D analogs in treating psoriasis are well investigated; their complementary effects lead to the disruption of the inflammatory feedback loop underlying psoriasis pathogenesis. Recent preclinical data showed that combination therapy is more effective than monotherapies of the active ingredients in preventing activation of resting pro-inflammatory cells, inducing immunomodulation, reducing inflammatory responses by regulating T cell production, and normalizing keratinocytes. The increased understanding of the mechanism of action of fixed-dose combination therapy from preclinical studies is supported by several clinical studies. As the efficacy of topical therapy is correlated with the skin penetration of the active ingredients, new drug delivery systems have been developed. The fixed-dose combination Cal/BD aerosol foam creates a modified supersaturated formulation when applied to the skin, which is maintained for at least 26 h in the laboratory setting. Clinical studies have demonstrated superior efficacy of fixed-dose combination calcipotriol (Cal) 50 µg/g and betamethasone dipropionate (BD) 0.5 mg/g aerosol foam compared with monotherapies of the active ingredients. Furthermore, Cal/BD aerosol foam has shown significantly improved efficacy compared with more traditional formulations, such as Cal/BD ointment and gel, in other studies. Calcipotriol also mitigates risks associated with betamethasone dipropionate and vice versa, resulting in the favorable safety profile observed with fixed-dose combination treatment. Recent data also suggest that fixed-dose combination treatment could provide long-term management of psoriasis, although further clinical investigations are needed. Overall, these data support the value of fixed-dose combination therapy of corticosteroid and vitamin D analog and highlight the added potential of innovative drug delivery for the treatment of psoriasis.LEO Pharma." @default.
• W2743134732 created "2017-08-17" @default.
• W2743134732 creator A5000743912 @default.
• W2743134732 creator A5011037498 @default.
• W2743134732 creator A5017062027 @default.
• W2743134732 creator A5054745950 @default.
• W2743134732 creator A5069983847 @default.
• W2743134732 creator A5082107704 @default.
• W2743134732 creator A5085831636 @default.
• W2743134732 date "2017-08-07" @default.
• W2743134732 modified "2023-10-18" @default.
• W2743134732 title "Optimizing Anti-Inflammatory and Immunomodulatory Effects of Corticosteroid and Vitamin D Analogue Fixed-Dose Combination Therapy" @default.
• W2743134732 cites W118002145 @default.
• W2743134732 cites W1547392960 @default.
• W2743134732 cites W1568007316 @default.
• W2743134732 cites W1761318064 @default.
• W2743134732 cites W1865488527 @default.
• W2743134732 cites W1883626840 @default.
• W2743134732 cites W1902683402 @default.
• W2743134732 cites W1934662830 @default.
• W2743134732 cites W1943767310 @default.
• W2743134732 cites W1963731011 @default.
• W2743134732 cites W1964487329 @default.
• W2743134732 cites W1979058179 @default.
• W2743134732 cites W198258450 @default.
• W2743134732 cites W1987430117 @default.
• W2743134732 cites W1988897543 @default.
• W2743134732 cites W1998625387 @default.
• W2743134732 cites W2000398006 @default.
• W2743134732 cites W2008086119 @default.
• W2743134732 cites W2009046177 @default.
• W2743134732 cites W2020760332 @default.
• W2743134732 cites W2025869037 @default.
• W2743134732 cites W2029128580 @default.
• W2743134732 cites W2038254867 @default.
• W2743134732 cites W2047344004 @default.
• W2743134732 cites W2059095993 @default.
• W2743134732 cites W2066236070 @default.
• W2743134732 cites W2066620976 @default.
• W2743134732 cites W2067018524 @default.
• W2743134732 cites W2072529751 @default.
• W2743134732 cites W2081482161 @default.
• W2743134732 cites W2085417241 @default.
• W2743134732 cites W2092720431 @default.
• W2743134732 cites W2095476253 @default.
• W2743134732 cites W2103018315 @default.
• W2743134732 cites W2104756393 @default.
• W2743134732 cites W2128792706 @default.
• W2743134732 cites W2133657961 @default.
• W2743134732 cites W2150275207 @default.
• W2743134732 cites W2160096806 @default.
• W2743134732 cites W2170609899 @default.
• W2743134732 cites W2203996567 @default.
• W2743134732 cites W2213987886 @default.
• W2743134732 cites W2292852002 @default.
• W2743134732 cites W2336320036 @default.
• W2743134732 cites W2345379764 @default.
• W2743134732 cites W2348752609 @default.
• W2743134732 cites W2431399654 @default.
• W2743134732 cites W2461044040 @default.
• W2743134732 cites W2507802241 @default.
• W2743134732 cites W2521073549 @default.
• W2743134732 cites W2561759163 @default.
• W2743134732 cites W2799409076 @default.
• W2743134732 cites W2986017612 @default.
• W2743134732 cites W4235076304 @default.
• W2743134732 cites W74634963 @default.
• W2743134732 doi "https://doi.org/10.1007/s13555-017-0196-z" @default.
• W2743134732 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5574747" @default.
• W2743134732 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28785924" @default.
• W2743134732 hasPublicationYear "2017" @default.
• W2743134732 type Work @default.
• W2743134732 sameAs 2743134732 @default.
• W2743134732 citedByCount "31" @default.
• W2743134732 countsByYear W27431347322017 @default.
• W2743134732 countsByYear W27431347322018 @default.
• W2743134732 countsByYear W27431347322019 @default.
• W2743134732 countsByYear W27431347322020 @default.
• W2743134732 countsByYear W27431347322021 @default.
• W2743134732 countsByYear W27431347322022 @default.
• W2743134732 countsByYear W27431347322023 @default.
• W2743134732 crossrefType "journal-article" @default.
• W2743134732 hasAuthorship W2743134732A5000743912 @default.
• W2743134732 hasAuthorship W2743134732A5011037498 @default.
• W2743134732 hasAuthorship W2743134732A5017062027 @default.
• W2743134732 hasAuthorship W2743134732A5054745950 @default.
• W2743134732 hasAuthorship W2743134732A5069983847 @default.
• W2743134732 hasAuthorship W2743134732A5082107704 @default.
• W2743134732 hasAuthorship W2743134732A5085831636 @default.
• W2743134732 hasBestOaLocation W27431347321 @default.
• W2743134732 hasConcept C126322002 @default.
• W2743134732 hasConcept C16005928 @default.
• W2743134732 hasConcept C2776009542 @default.
• W2743134732 hasConcept C2776623344 @default.
• W2743134732 hasConcept C2776804153 @default.
• W2743134732 hasConcept C2776999253 @default.
• W2743134732 hasConcept C2779800615 @default.
• W2743134732 hasConcept C2780035454 @default.

• next